Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis

Am J Trop Med Hyg. 2012 Sep;87(3):435-6. doi: 10.4269/ajtmh.2012.12-0114. Epub 2012 Jul 23.

Abstract

We report a case of severe malaria in a patient with underlying myasthenia gravis who was successfully treated with artesunate. The outcome was favorable. Artesunate seems to be a good option for patients with underlying myasthenia gravis disease because they benefit from a better toxicity profile than quinine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Artemisinins / therapeutic use*
  • Artesunate
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Male
  • Myasthenia Gravis / parasitology*
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / pathogenicity
  • Treatment Outcome

Substances

  • Artemisinins
  • Artesunate